ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,568 | -99.7% | 29,218 | +123.0% | 0.01% | +150.0% |
| Q2 2022 | $1,218,000 | +413.9% | 13,105 | +548.8% | 0.00% | – |
| Q1 2022 | $237,000 | -39.8% | 2,020 | -42.3% | 0.00% | -100.0% |
| Q1 2020 | $394,000 | -70.2% | 3,500 | -74.5% | 0.00% | -66.7% |
| Q3 2019 | $1,320,000 | -18.3% | 13,700 | -46.9% | 0.00% | -25.0% |
| Q4 2018 | $1,616,000 | +12.2% | 25,799 | +27.0% | 0.00% | +33.3% |
| Q3 2018 | $1,440,000 | -25.2% | 20,315 | -29.8% | 0.00% | -40.0% |
| Q2 2018 | $1,926,000 | – | 28,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |